MI-463

• Description:

  MI-463 is a highly potent and orally bioavailable small molecule inhibitor of the menin-mLL interaction.

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H315, H319, H335

• Target:

  Epigenetic Reader Domain

• Type:

  Reference compound

• Related Pathways:

  Epigenetics

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/MI-463.html

• Purity:

  99.66

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  FC (F) (F) CC (S1) =CC2=C1N=CN=C2NC3CCN (CC4=CC=C (NC (C#N) =C5) C5=C4C) CC3

• Molecular Formula:

  C24H23F3N6S

• Molecular Weight:

  484.54

• Precautions:

  H302, H315, H319, H335

• References & Citations:

  [1]Borkin D, et al. Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo. Cancer Cell. 2015 Apr 13;27 (4) :589-602.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  1628317-18-9